IBS, The Microbiome and a Novel Virtual Tool
Written by: CDHF
Updated: November 16th, 2022
This presentation was done at CDHF’s #TrendingNow: Putting the Biggest Gut Health Trends under the Microscope November-January 2022 by Dr. James C Gregor, Gastroenterologist Professor of Medicine in in the Departments of Medicine in the Schulich School of Medicine and Dentistry at Western University.
Learning Objectives:
- To introduce the Brain, Gut and Microbiome axis and highlight that IBS is multifactorial
- To review therapeutic options that target the microbiome (the nonsystemic antibiotic rifaximin, prebiotics, probiotics, and dietary modification
- To bring awareness that digital technology can support the patient and the physician: The myIBS APP
About the Speaker: Dr. James C. Gregor is a Professor of Medicine in the Departments of Medicine in the Schulich School of Medicine and Dentistry at Western University. Dr. Gregor graduated from the University of Western Ontario in 1988, and specialized in Internal Medicine and Gastroenterology. He did further training in Clinical Epidemiology and Health Economics at the University of Toronto. Dr. Gregor joined the Medical Staff at The London Health Sciences Centre in 1995. He served as Program Director for the Division of Gastroenterology from 1998 to 2009. Currently he is the Site Chief for the Department of Medicine at the LHSC-Victoria Hospital, Associate Chair of Medicine at Western University. Dr. Gregor is past President of the Ontario Association of Gastroenterology and he is past Chair of the Specialty Committee in Gastroenterology for the Royal College of Physicians & Surgeons of Canada. His research interests include therapeutic endoscopy, inflammatory bowel disease, celiac disease and economic analysis and quality of life assessments in Gastroenterology.
This presentation was made possible due to an unrestricted educational grant from Lupin Pharma Canada Ltd.
